logo
Share SHARE
FONT-SIZE Plus   Neg

Consort Medical FY Pretax Profit Rises; Revenue Up 6.2% - Quick Facts

Consort Medical plc (CSRT.L) reported pretax profit of 21.9 million pounds for the year ended 30 April 2017 compared to 11.3 million pounds, previous year. Profit for the financial year from continuing operations was 22.6 million pounds or 45.7 pence per share compared to 16.0 million pounds or 32.3 pence per share. Profit before tax before special items was 35.6 million pounds compared to 32.3 million pounds. Adjusted earnings per ordinary share from continuing operations increased to 64.4 pence from 56.8 pence.

Fiscal year Group revenue increased by 6.2% to 294.0 million pounds from 276.9 million pounds, prior year. Bespak delivered growth of 3.3% to 121.1 million pounds while Aesica revenue grew by 8.2% to 172.9 million pounds. The Group achieved underlying growth of 2% at constant exchange rates.

The Board of Consort Medical proposed an increased final dividend of 13.21 pence, making a total dividend for the year of 20.30 pence.

Jon Glenn, CEO of Consort Medical, said: "Group performance is expected to be broadly in line with our near-term expectations for the current financial year, despite some headwinds from contract phasing. The Board remains confident about the prospects for the Group."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Wal-Mart Stores Inc., the world's largest retailer, reported a decline in second-quarter profit with a significant charge. Adjusted earnings topped analysts' estimates with higher comparable sales. Looking ahead, for the third quarter, the company projects earnings in line or below market view. The company also issued earnings forecast for fiscal 2018. The development of Alzheimer's drugs has been marred by a high failure rate. A U.S. study, which analyzed how the Alzheimer's clinical trials fared during the period of 2002 to 2012, revealed a failure rate of 99.6% compared to a failure rate of 81% for cancer drugs. Apple Inc. plans to invest roughly $1 billion to procure and produce original content over the next year, The Wall Street Journal reported, citing people familiar with the matter. The planned investment in Hollywood reportedly could result in as many as 10 new shows.
comments powered by Disqus
Follow RTT